SCHEMBL273486

SCHEMBL273486

c1ccc2c(c1)ncn2SSn1cnc2ccccc21

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.52
▸ HTT P42858 4/20 0.50
▸ CYP11B1 P15538 3/20 0.46
▸ CYP11B2 P19099 3/20 0.46
▸ POLB P06746 1/20 0.46
▸ TNF P01375 1/20 0.46
▸ FGFR1 P11362 1/20 0.44
▸ LMNA P02545 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ STAT6 P42226 1/20 0.43
▸ PKM P14618 1/20 0.42
▸ MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8013907 0.86 TDP1 (0.52) TDP1HTTCYP11B1CYP11B2POLB
SCHEMBL16401979 0.83 TDP1 (0.46) TDP1HTTCYP11B1CYP11B2TNF
SCHEMBL6381049 0.83 TDP1 (0.48) TDP1HTTCYP11B1CYP11B2POLB
SCHEMBL20683088 0.83 TDP1 (0.48) TDP1HTTCYP11B1CYP11B2POLB
SCHEMBL1879818 0.79 HTT (0.48) TDP1HTTCYP11B1CYP11B2POLB
SCHEMBL3805246 0.79 TDP1 (0.42) TDP1HTTCYP11B1CYP11B2POLB
SCHEMBL8413080 0.78 TDP1 (0.48) TDP1HTTCYP11B1CYP11B2POLB
SCHEMBL9060998 0.78 TDP1 (0.48) TDP1HTTCYP11B1CYP11B2TNF
SCHEMBL15525424 0.78 TDP1 (0.44) TDP1HTTCYP11B1CYP11B2POLB
SCHEMBL14722522 0.78 TDP1 (0.44) TDP1HTTCYP11B1CYP11B2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030176512-A1 Asymmetric disulfides and methods of using same PROLX PHARMACEUTICALS CORPORATION (CA) 2003-09-18 — — US claimed
WO-2023233895-A1 POLYIMIDE RESIN PRECURSOR 東京応化工業株式会社 2023-12-07 — — WO disclosed
WO-2023233896-A1 PHOTOSENSITIVE RESIN COMPOSITION 東京応化工業株式会社 2023-12-07 — — WO disclosed
WO-2023176172-A1 POLYIMIDE RESIN PRECURSOR 東京応化工業株式会社 2023-09-21 — — WO disclosed
US-8530003-B2 Polybenzoxazole precursor, photosensitive resin composition using the same, and manufacturing method of semiconductor device FUJIFILM CORPORATION (JP) 2013-09-10 — — US disclosed
US-20120115333-A1 POLYBENZOXAZOLE PRECURSOR, PHOTOSENSITIVE RESIN COMPOSITION USING THE SAME, AND MANUFACTURING METHOD OF SEMICONDUCTOR DEVICE FUJIFILM CORPORATION (JP) 2012-05-10 — — US disclosed
US-8133550-B2 Good breaking elongation characteristics, achievable high sensitivity and high film remaining rate, little in pattern size fluctuation at the heating time after lithographic process, capable of stable pattern formation; manufacturing a semiconductor device FUJIFILM CORPORATION (JP) 2012-03-13 — — US disclosed
WO-2009082686-A1 COMPOSITIONS AND METHODS FOR USING ASYMMETRIC DISULFIDES PROLX PHARMACEUTICALS CORP. (US) 2009-07-02 — — WO disclosed
US-20080076849-A1 POLYBENZOXAZOLE PRECURSOR, PHOTOSENSITIVE RESIN COMPOSITION USING THE SAME, AND MANUFACTURING METHOD OF SEMICONDUCTOR DEVICE FUJIFILM CORPORATION (JP) 2008-03-27 — — US disclosed
EP-1786477-A2 METHOD OF PRESELECTION PATIENTS FOR ANTI-VEGF, ANTI-HIF-1 OR ANTI-THIOREDOXIN THERAPY Prolx Pharmaceuticals Corp. (US) 2007-05-23 — — EP disclosed
WO-2005007108-A2 ASYMMETRIC DISULFIDES AND METHODS OF USING SAME PROLX PHARMACEUTICALS, INC. (US) 2005-01-27 — — WO disclosed
US-20040116496-A1 Asymmetric Disulfides and methods of using same PROLX PHARMACEUTICALS CORP. 2004-06-17 — — US disclosed
US-20030176512-A1 Asymmetric disulfides and methods of using same PROLX PHARMACEUTICALS CORPORATION (CA) 2003-09-18 — — US disclosed
US-6552060-B1 Inhibits abnormal cellular proliferation and restores or prevents inhibition of cellular apoptosis PROLX PHARMACEUTICALS, INC. 2003-04-22 — — US disclosed
US-4599428-A SALT FORMATION, THIOETHERIFICATION CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT (HU) 1986-07-08 — — US disclosed
US-4473697-A WITH GASEOUS CHLORINE AND A RHODANIDE CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA R.T. (HU) 1984-09-25 — — US disclosed
EP-0027646-B1 PROCESS FOR THE PREPARATION OF BENZIMIDAZOLE DERIVATIVES CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. (HU) 1984-03-07 — — EP disclosed
US-4275073-A PENTATHIEPINOPYRAZOLES AND PYRAZOLOTRITHIOCARBONATES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1981-06-23 — — US disclosed
EP-0027646-A1 Process for the preparation of benzimidazole derivatives CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. (HU) 1981-04-29 — — EP disclosed
US-4259344-A FUNGICIDES, ANTHELMINTICS CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA R.T. (HU) 1981-03-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115333-A1 POLYBENZOXAZOLE PRECURSOR, PHOTOSENSITIVE RESIN COMPOSITION USING THE SAME, AND MANUFACTURING METHOD OF SEMICONDUCTOR DEVICE CD79B, BRIX1, SMARCB1 TDP1 1732/4885HTT 2882/4885CYP11B1 3379/4885
US-20030176512-A1 Asymmetric disulfides and methods of using same PRDX3, PDIA5, PRDX5 TDP1 3261/4885HTT 2505/4885CYP11B1 329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback